BigHat Biosciences
BigHat Biosciences builds an AI-enabled, high-throughput wet-lab platform to design and optimize antibody therapeutics for biotech and pharma R&D teams. The privately held company develops internal drug programs and collaborates with partners, using machine learning, robotics, and proprietary datasets to accelerate discovery-to-optimization workflows. Founded in 2019 and headquartered in San Mateo, California, it focuses on next-generation biologics for difficult diseases.
Open Positions at BigHat Biosciences
1 open position
Develop state-of-the-art machine learning models for therapeutic antibody sequence, structure, and property design, with results validated through high-throughput wet-lab synthesis. This interdisciplinary role combines novel ML research, LLM-driven optimization, and hands-on drug development.